Skip to content

ACER THERAPEUTICS INC.: filings

Every ACER THERAPEUTICS INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 53 filings, each linked to its SEC index.

Filing record ends 2023-11-20

The latest filing in this captured record is a 10-Q filed 2023-11-20. No later filing is in the SEC companyfacts record captured on 2026-09-22. ACER THERAPEUTICS INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-11-20fiscal Q3 2023461240000950170-23-065159
10-Q2023-08-14fiscal Q2 2023431170000950170-23-042436
10-Q2023-05-15fiscal Q1 202342840000950170-23-022296
10-K2023-03-27fiscal FY 202243860000950170-23-009992
10-Q2022-11-14fiscal Q3 2022431200001564590-22-037680
10-Q/A2022-11-14fiscal Q2 2022431170001564590-22-037667
10-Q2022-08-15fiscal Q2 2022421130001564590-22-029495
10-Q2022-05-16fiscal Q1 202237760001564590-22-020405
10-K2022-03-02fiscal FY 202138770001564590-22-008350
10-Q2021-11-19fiscal Q3 202137990001564590-21-057798
10-Q/A2021-11-19fiscal Q2 202137930001564590-21-057787
10-Q/A2021-11-19fiscal Q1 202140760001564590-21-057782
10-Q2021-08-10fiscal Q2 202137930001564590-21-043099
10-Q2021-05-17fiscal Q1 202140760001564590-21-028403
10-K2021-03-01fiscal FY 202038770001564590-21-009909
10-Q2020-11-10fiscal Q3 202037990001564590-20-052987
10-Q2020-08-13fiscal Q2 202037940001564590-20-040040
10-Q2020-05-14fiscal Q1 202035710001564590-20-025470
10-K2020-03-18fiscal FY 201937750001564590-20-011639
10-Q2019-11-13fiscal Q3 201936990001564590-19-043229
10-Q2019-08-13fiscal Q2 201935920001564590-19-031810
10-Q2019-05-14fiscal Q1 201935710001564590-19-019149
10-K2019-03-07fiscal FY 201832660001564590-19-006779
10-Q2018-11-09fiscal Q3 201829740001564590-18-028926
10-Q2018-08-13fiscal Q2 201829720001564590-18-021463
10-Q2018-05-14fiscal Q1 201823470001564590-18-013413
10-K2018-03-07fiscal FY 201725530001564590-18-004714
10-Q2017-11-13fiscal Q3 201723600001654954-17-010486
10-Q2017-08-14fiscal Q2 201721540001654954-17-007407
10-Q2017-05-12fiscal Q1 201721440001654954-17-004492
10-K2017-03-28fiscal FY 201624500001654954-17-002641
10-Q2016-11-14fiscal Q3 201622560001654954-16-003838
10-Q2016-08-11fiscal Q2 201622560001654954-16-001412
10-Q2016-05-12fiscal Q1 201621440001354488-16-007356
10-K2016-03-15fiscal FY 201524500001354488-16-006584
10-Q2015-11-10fiscal Q3 201522560001354488-15-004934
10-Q2015-08-12fiscal Q2 201522560001354488-15-003743
10-Q2015-05-12fiscal Q1 201521440001354488-15-002305
10-K2015-02-23fiscal FY 201425520001157523-15-000646
10-Q2014-11-06fiscal Q3 201422580001157523-14-004456
10-Q2014-08-14fiscal Q2 201422530001157523-14-003490
10-Q2014-05-14fiscal Q1 201423540001157523-14-002173
10-K2014-02-27fiscal FY 201329870001157523-14-000869
10-Q2013-11-07fiscal Q3 201328780001157523-13-005403
10-Q2013-08-14fiscal Q2 201328770001157523-13-004103
10-Q2013-05-14fiscal Q1 201328670001157523-13-002641
10-K2013-03-29fiscal FY 201228830001157523-13-001603
10-Q2012-11-14fiscal Q3 201225710001157523-12-006038
10-Q2012-08-13fiscal Q2 201225700001157523-12-004482
10-Q2012-05-11fiscal Q1 201225600001157523-12-002801
10-K2012-02-27fiscal FY 201126760001157523-12-001047
10-Q2011-11-04fiscal Q3 201123640001157523-11-006466
10-Q2011-08-11fiscal Q2 201123640001157523-11-004942

Inspect the source

Entity
ACER THERAPEUTICS INC. / CIK 0001069308
Captured
SEC response SHA-256
d41ecd9c66d537efeeb403c8604fe32734f808b5d83b00a9acc9f0ba72164b38

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001069308.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))